收费全文 | 23391篇 |
免费 | 1904篇 |
国内免费 | 81篇 |
耳鼻咽喉 | 231篇 |
儿科学 | 994篇 |
妇产科学 | 506篇 |
基础医学 | 3048篇 |
口腔科学 | 698篇 |
临床医学 | 2604篇 |
内科学 | 4905篇 |
皮肤病学 | 440篇 |
神经病学 | 2157篇 |
特种医学 | 1217篇 |
外科学 | 3134篇 |
综合类 | 338篇 |
一般理论 | 16篇 |
预防医学 | 1911篇 |
眼科学 | 468篇 |
药学 | 1451篇 |
中国医学 | 42篇 |
肿瘤学 | 1216篇 |
2022年 | 215篇 |
2021年 | 458篇 |
2020年 | 258篇 |
2019年 | 406篇 |
2018年 | 505篇 |
2017年 | 380篇 |
2016年 | 474篇 |
2015年 | 496篇 |
2014年 | 583篇 |
2013年 | 919篇 |
2012年 | 1243篇 |
2011年 | 1253篇 |
2010年 | 758篇 |
2009年 | 751篇 |
2008年 | 1123篇 |
2007年 | 1191篇 |
2006年 | 1159篇 |
2005年 | 1048篇 |
2004年 | 1021篇 |
2003年 | 852篇 |
2002年 | 843篇 |
2001年 | 570篇 |
2000年 | 534篇 |
1999年 | 479篇 |
1998年 | 330篇 |
1997年 | 310篇 |
1996年 | 287篇 |
1995年 | 250篇 |
1994年 | 214篇 |
1993年 | 225篇 |
1992年 | 333篇 |
1991年 | 340篇 |
1990年 | 369篇 |
1989年 | 362篇 |
1988年 | 295篇 |
1987年 | 306篇 |
1986年 | 302篇 |
1985年 | 291篇 |
1984年 | 241篇 |
1983年 | 209篇 |
1982年 | 175篇 |
1981年 | 131篇 |
1980年 | 157篇 |
1979年 | 178篇 |
1978年 | 158篇 |
1977年 | 156篇 |
1976年 | 175篇 |
1975年 | 141篇 |
1974年 | 135篇 |
1972年 | 131篇 |
Areas covered: This article covers the pharmacokinetics and pharmacodynamics of vilazodone and provides an evaluation of the clinical usefulness of vilazodone for the treatment of MDD and anxiety disorders. A literature search was performed using PubMed/MEDLINE, Web of Science and the Cochrane Library.
Expert opinion: Studies have shown that vilazodone is significantly superior to placebo. However, vilazodone cannot as yet be recommended as a first-line treatment option for MDD as it is unclear whether the drug’s dual mechanism of action provides greater efficacy than prevailing treatment options. Moreover, more phase IV studies are needed to establish its efficacy and long-term safety in larger and more diverse populations. Although vilazodone may have an additional advantage for the treatment of anxiety symptoms in MDD, here also additional studies are required to confirm its efficacy over and above SSRI alternatives and other antidepressant treatments. Therefore, presently, vilazodone should be considered as a second- or third-line treatment option for MDD and GAD. 相似文献
Methods: 3,742 individuals with T1D age ≥50 were followed for dementia from 1/1/96-9/30/2015. Depression, dementia, and comorbidities were abstracted from electronic medical records. Cox proportional hazard models estimated the association between depression and dementia adjusting for demographics, glycosylated hemoglobin, severe dysglycemic epidsodes, stroke, heart disease, nephropathy, and end stage renal disease. The cumulative incidence of dementia by depression was estimated conditional on survival dementia-free to age 55.
Results: Five percent (N = 182) were diagnosed with dementia and 20% had baseline depression. Depression was associated with a 72% increase in dementia (fully adjusted HR = 1.72; 95% CI:1.12-2.65). The 25-year cumulative incidence of dementia was more than double for those with versus without depression (27% vs. 12%).
Conclusions: For people with T1D, depression significantly increases dementia risk. Given the pervasiveness of depression in T1D, this has major implications for successful aging in this population recently living to old age. 相似文献
Methods: In this prospective observational study, 15 volunteers underwent sciatic nerve examination using a curved ultrasound probe in the range of 2-5 MHz and a Philips-ATL 5000 unit (ATL Ultrasound, Bothell, WA) in the gluteal, infragluteal, and proximal thigh regions. Thereafter, an insulated block needle was advanced inline with the ultrasound beam to reach the nerve target, which was further confirmed by electrical stimulation. The quality of sciatic nerve images, ease of needle to nerve contact, threshold stimulating current, and resultant motor response were recorded.
Results: The sciatic nerve was successfully identified in the transverse view as a solitary predominantly hyperechoic structure on ultrasound in all of the three regions examined. The target nerve was visualized easily in 87% and localized within two needle attempts in all patients. Nerve stimulation was successful in 100% after two attempts with a threshold current of 0.42 +/- 0.12 (mean +/- SD) eliciting foot plantarflexion or dorsiflexion. 相似文献